V R Zurawski

No ORCID on file · 5 papers in corpus · active 1982-1989

Study types

  • other 5

Condition tags

  • endometriosis 5
other 1989
Gynecologic oncology ·doi:10.1016/0090-8258(89)90169-8

Twenty patients with recurrent or persistent epithelial ovarian cancer failing conventional therapies were treated with a single intraperitoneal injection of iodine-131-labeled OC 125 monoclonal antibody. Rare acute side effects were nausea…

other 1986
American Journal of Obstetrics and Gynecology ·doi:10.1016/0002-9378(86)90269-3

Serum CA 125 levels were determined in 64 women with benign ovarian lesions, 92 women with uterine fundal lesions, and six patients who had negative second-look laparotomy for epithelial ovarian carcinoma. Of those with benign lesions, 13 o…

other 1984
American Journal of Obstetrics and Gynecology ·doi:10.1016/0002-9378(84)90035-8

CA 125 and CA 19-9 are antigenic determinants associated with human epithelial ovarian carcinomas. Murine monoclonal antibodies have been raised against these determinants, and immunoradiometric assays have been developed to monitor antigen…

other 1983
The New England journal of medicine ·doi:10.1056/NEJM198310133091503

The murine monoclonal antibody OC 125 reacts with an antigen (CA 125) common to most nonmucinous epithelial ovarian carcinomas. An assay has been developed to detect CA 125 in serum. By this assay, only 1 per cent of 888 apparently healthy …

other 1982
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists ·doi:10.1097/00004347-198203000-00001

An immunoperoxidase study, using the Avidin-Biotin-Peroxidase complex method and the monoclonal antibodies, anti-carcinoembryonic antigen (CEA) and anti-carbohydrate determinant 19-9 (CA 19-9), was carried out on 108 common epithelial tumor…